Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 20.1% in September

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a significant decrease in short interest in September. As of September 15th, there was short interest totalling 182,100 shares, a decrease of 20.1% from the August 31st total of 227,800 shares. Based on an average daily volume of 2,000,000 shares, the days-to-cover ratio is currently 0.1 days.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. HC Wainwright reduced their price target on shares of Aethlon Medical from $10.00 to $7.00 and set a “buy” rating on the stock in a research report on Monday, June 24th. StockNews.com assumed coverage on shares of Aethlon Medical in a research report on Saturday, September 21st. They set a “sell” rating on the stock.

Aethlon Medical Stock Performance

AEMD stock opened at $0.48 on Friday. The company’s 50 day moving average price is $0.39 and its 200 day moving average price is $0.79. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $2.40. The firm has a market capitalization of $6.63 million, a price-to-earnings ratio of -0.09 and a beta of 1.72.

Aethlon Medical (NASDAQ:AEMD) last released its earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.10. During the same quarter in the previous year, the business earned ($1.30) EPS. Equities analysts forecast that Aethlon Medical will post -1.1 EPS for the current fiscal year.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.